Prognostic Model of HCV-related Disease Progression After DAAs

NCT04631640 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2020-11-17

No results posted yet for this study

Summary

In this study, the investigator would conduct an ambispective cohort study to build a prediction model of HCV-related disease after DAAs.

Conditions

  • HCV

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Huixin Liu, Ph.D. · Peking University People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04631640 on ClinicalTrials.gov